Life Sciences - Healthcare News | October 2023
Innovative start-ups are booming in Germany's attractive life sciences sector.
Your company is already operating in Germany and you would now like to export worldwide?
Innovative start-ups are booming in Germany's attractive life sciences sector.
Germany's life sciences sector is proving attractive to start-up investors and international health companies alike.
Germany's medical technology sector secured more than EUR 2 billion in investment in 2021, with start-up companies and larger corporations alike developing great innovations.
Germany's life sciences sector was the top medical device FDI destination in 2019 and 2020. Companies including Bayer and BioNTech are also expanding their footprint in the country.
Germany's biotech firms are booming, innovations are being made using 3D printing and digital apps are an export hit in the thriving life sciences sector.
The life sciences sector is carrying out mRNA-based research to develop vaccines for cancer, novel gene and cell therapies to treat Parkinson's, and providing a home for global pandemic research.
Germany's life sciences market continues to attract international investors in sectors ranging from coronavirus vaccine production to medical cannabis products.